88IV - PR Newswire Asia's news - Medical/Pharmaceuticals


Dr. Vein, a Specialist Varicose Vein Clinic in Ho Chi Minh City, Sets Out Its Treatment Pathway for Patients Travelling from the United States HO CHI MINH CITY, Vietnam , Oct. 9, 2026 /PRNewswire/ -- Dr. Vein Clinic, a medical facility in central Ho Chi Minh City specializing in the examination and treatment of varicose veins, has set out the ... 2026-10-09T Health Care/Hospital Medical/Pharmaceuticals Travel
India Mental Health Alliance (IMHA) champions lived experience as central to shaping mental healthcare practice, service design and policy NEW DELHI , Oct. 9, 2026 /PRNewswire/ -- On the occasion of World Mental Health Day (10th October), the India Mental Health Alliance (IMHA), a cross-sectoral network of 400 organisations from 30 Indian ... 2026-10-09T Health Care/Hospital Medical/Pharmaceuticals Publishing/Information Service
Antengene to Present Latest Preclinical Results of ATG-207 (αCD3-TGF-β Bifunctional Fusion Protein) at ACR 2026 SHANGHAI and HONG KONG , Oct. 9, 2026 /PRNewswire/ -- Antengene Corporation Limited ( "Antengene" , SEHK: 6996.HK) , a leading innovative, commercial-stage global biotech company dedicated ... 2026-10-09T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Everest Medicines Appoints Two Veteran mRNA Cancer Vaccine Scientists to Advance Global Clinical Development Lakshmi Srinivasan, PhD, former Executive Director and Head of Oncology Translational Medicine at Moderna, and Brandon Coder, PhD, former Research & Early Translational Lead, Cancer Vaccines at Moderna, ... 2026-10-09T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Innovent Announces Phase 3 RESTORE-3 Study of SYCUME® (Teprotumumab N01 Injection) Met Primary Endpoint in Inactive Thyroid Eye Disease SYCUME ® Significantly Improved Proptosis (Response Rate 60.4% / LS Mean Change from Baseline -1.88 mm) with Favorable Safety Profile in Participants with Inactive Thyroid Eye Disease(TED) SAN ... 2026-10-09T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Telix to Host Capital Markets Day in Melbourne on November 4, 2026 MELBOURNE, Australia and INDIANAPOLIS , Oct. 9, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announced that it will host a Capital Markets Day in ... 2026-10-09T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
GenScript Launches Life Sciences Startup PitchFest with NVIDIA to Accelerate Biotech Innovation Inaugural competition will connect emerging AI life sciences platforms with validation expertise, investors, and ecosystem partners during JPM Week ... 2026-10-08T Biotechnology Computer/Electronics Health Care/Hospital Medical/Pharmaceuticals
Wellysis Secures FDA 510(k) Clearance for AI-Powered ECG Analysis Software, S-Patch CardioAI Adds FDA-cleared AI analysis to Wellysis' S-Patch ECG monitoring solution, expanding its capabilities beyond ECG acquisition Enables FDA-cleared AI analysis of S-Patch ECG data to be integrated into ... 2026-10-08T Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
China SXT Pharmaceuticals Inc. Announces $12 Million Registered Direct Offering TAIZHOU, China , Oct. 8, 2026 /PRNewswire/ -- China SXT Pharmaceuticals Inc. (NASDAQ: SXTC) (the "Company"), today announced that it has entered into a definitive agreement with certain ... 2026-10-08T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
SECuRE update: recruitment target of the Cohort Expansion Main Group achieved SYDNEY , Oct. 8, 2026 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation ... 2026-10-08T Biotechnology Health Care/Hospital Medical/Pharmaceuticals

PR Newswire Asia's news > Medical/Pharmaceuticals